Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Wednesday broker round-up UPDATE

Wed, 19th Jun 2013 08:27
Aggreko: UBS cuts target price from 1975p to 1850p downgrading from buy to neutral. JP Morgan revises target price from 1870p to 1800p and retains a neutral rating.Alliance Pharma: Investec shifts target price from 35.20p to 35.80p, while downgrading from add to hold.Associated British Food: UBS reduces target price from 2080p to 2030p, while its buy recommendation remains unchanged.Barclays: Morgan Stanley shifts target price from 424p to 431p and keeps an overweight rating.Cable & Wireless Communications: Berenberg lowers target price from 42p to 40p and reiterates its buy recommendation.Capita: JP Morgan raises target price from 875p to 1070p maintaining an overweight rating.Coal of Africa: Investec ups target price from 15p to 20p and upgrades from hold to buy.Daily Mail & General Trust: Deutsche Bank reduces target price from 660p to 590p and downgrades to sell.Ferrexpo: Investec initiates with a target price of 215p and a buy recommendation.Imagination Technologies: Investec places both its target price (prev.: 395p) and its hold recommendation under review.JD Sports Fashion: Investec ups target price from 860p to 940p retaining its buy recommendation.Kingfisher: Bank of America increases target price from 290p to 375p and upgrades to neutral.Lancashire: JP Morgan reduces target price from 860p to 800p downgrading from overweight to neutral.Man Group: Canaccord Genuity cuts target price from 120p to 110p keeping a buy recommendation.Micro Focus: Panmure Gordon takes target price from 693p to 716p reiterating a buy recommendation. Canaccord Genuity raises target price from 800p to 820p ad retains a buy recommendation.Pennant International: WH Ireland ups target price from 90p to 99p and keeps a buy recommendation.SABMiller: Morgan Stanley raises target price from 3300p to 3435p retaining an equal-weight rating.SDL: Citi cuts target price from 485p to 330p, while reiterating its buy recommendation.Spirent Communications: Bank of America initiates with a target price of 162p and a buy recommendation.SQS Software Quality: Panmure Gordon moves target price from 336p to 347p and maintains a buy recommendation.Whitbread: HSBC Holdings increases target price from 2900p to 3400p retaining an overweight rating.

Related News

LONDON BROKER RATINGS: Citi raises Informa; RBC cuts Admiral
1 day ago

LONDON BROKER RATINGS: Citi raises Informa; RBC cuts Admiral

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

Premier Inn owner Whitbread says forward bookings outpacing last year
2 days ago

Premier Inn owner Whitbread says forward bookings outpacing last year

* Q1 LFL sales up 2% as hotel demand ​offsets F&B ⁠weakness

Alliance Pharma News

Alliance Pharma loss narrows in 2024 due to reduced impairment charges
8 Apr 2025

Alliance Pharma loss narrows in 2024 due to reduced impairment charges

(Alliance News) - Alliance Pharma PLC on Tuesday reported a narrowed loss for 2024 despite a decline in revenue, due to a reduction in impairment char...

Alliance Pharma confident despite softer sales
8 Apr 2025

Alliance Pharma confident despite softer sales

(Sharecast News) - Alliance Pharma posted weaker full-year revenues on Tuesday, but insisted it remained well-positioned for medium-term growth.

Alliance Pharma board backs final GBP362 million takeover bid
10 Mar 2025

Alliance Pharma board backs final GBP362 million takeover bid

(Alliance News) - Alliance Pharma PLC on Monday said it has agreed to a final increased cash offer of 64.75 pence per share from Dbay Advisors Ltd and...

Alliance Pharma agrees to take-private deal
10 Mar 2025

Alliance Pharma agrees to take-private deal

(Sharecast News) - Speciality drugmaker Alliance Pharma has agreed to be taken private in a deal valued at more than £360.0m.

Alliance Pharma expects to post flat annual profit, revenue decline
31 Jan 2025

Alliance Pharma expects to post flat annual profit, revenue decline

(Alliance News) - Alliance Pharma PLC on Friday said it expects to report 2024 profit broadly in line with the year before, despite a decline in annua...

LONDON BROKER RATINGS: Jefferies likes Volex; UBS raises Next
31 Jan 2025

LONDON BROKER RATINGS: Jefferies likes Volex; UBS raises Next

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: